This site is the entire property of APIMAB LABORATOIRES.
Any reproduction, even partial, of this site is strictly prohibited.
APIMAB LABORATOIRES SAS.
Adresse : Avenue du lac 34800 Clermont l’Hérault France
Tel : +33 (0)4 67 96 38 14
Publication Director: Simon BERNARD
APIMAB LABORATOIRES (France)
RCS: 353 242 886 MONTPELLIER
Share Capital: 171 500 euros
TVA NUMBER: FR81353242886
DEVELOPING AND HOSTING
Adresse : 65 Rue du Bourbonnais, 69009 Lyon, France
The site accessible by the URL www.propolia.com is exploited respecting French legislation. The use of this site is governed by these general conditions. By using the site, you acknowledge being aware of these conditions and having accepted them. They may be modified at any time without prior notification by the company APIMAB LABORATOIRES.
APIMAB LABORATOIRES will not be held liable in any way for misuse of the service.
In application of the French Intellectual Property Code, and more generally, international treaties and agreements containing provisions regarding the protection of copyright, you are prohibited from reproducing the information, presentation or organisation of the site for a use other than private use, and from selling, distributing, transmitting, disseminating, adapting, modifying, publishing, or communicating, fully or partially, in any form without our prior written authorisation.
LIMITATION OF LIABILITY
The information contained on this site is as precise as possible and the site is periodically updated, but may still contain inaccuracies, omissions or flaws. If you find a flaw, error, or what seems to be a malfunction, please communicate this by email, describing the problem as precisely as possible (page posing a problem, triggering action, type of computer and browser used, etc.).
All content downloaded is downloaded at the risk of the user and under their sole responsibility. As a result, APIMAB LABORATOIRES will not be held liable for any damage suffered by the browser of the user or any loss of data following download.
Photos are non-contractual.
The hyperlinks put in place in the context of this website to other resources on the internet do not entail the liability of APIMAB LABORATOIRES.
These conditions are governed by French law, and all disagreements or disputes which may arise in their interpretation or execution will be the exclusive competence of the relevant courts of the company headquarters of APIMAB LABORATOIRES. the language of reference, for settlement of potential disputes, is French.
DECLARATION TO THE NATIONAL COMMISSION FOR DATA PROTECTION AND LIBERTIES (CNIL)
In accordance with law 78-17 of the 6th of January 1978 (modified by law 2004-801 of the 6th of August 2004 regarding protection of natural persons with regard to processing of personal data) regarding computers, files and liberties, the site is subject to a declaration before the National Commission for Data Protection and Liberties (www.cnil.fr).
RIGHT OF ACCESS
In application of this law, internet users have a right of access, rectification, modification and deletion regarding the data which relates to them personally. This right may be exercised by writing to APIMAB LABORATOIRES Avenue du lac 34800 Clermont l’Hérault or by emailing firstname.lastname@example.org
The personal data collected is in no case transferred to third parties except for the potential proper execution of the service ordered by the internet user.
Your personal data is confidential and will in no case be communicated to third parties except for the proper execution of the service.
All content of this site, including but not limited to graphics, images, text, videos, animations, sounds, logos, gifs and icons, as well as their formatting are the exclusive property of the company APIMAB LABORATOIRES except for the brands, logos or content belonging to other partner companies or creators.
All reproduction, distribution, modification, adaptation, retransmission or publication, even partial, of these different elements is strictly prohibited without the express written agreement of APIMAB LABORATOIRES. This representation or reproduction, by any process, constitutes an infringement sanctioned by articles L.335-2 and following of the Intellectual Property Code. Non-respect for this restriction constitutes an infringement which may entail civil and penal liability for the infringing party. Furthermore, the owners of the copied Content may take legal action against you.
APIMAB LABORATOIRES is also owner of the “rights of producers of databases” set out in Book III, Title IV of the Intellectual Property Code (law n° 98-536 of the 1st of July 1998) regarding copyright and databases.
Users and visitors of the website may place a hyperlink to this site, but only to the home page, accessible at the URL www.propolia.com, on the condition that this link opens in a new window. In particular, a link to a subpage (“deep link”) is prohibited, as is opening this site by framing, without the prior express authorisation of APIMAB LABORATOIRES.
For all requests for authorisation or information, please contact us by email: Specific conditions are established for the press.
Furthermore, the formatting of this site requires resources from external sources for which we have acquired rights or whose usage rights are open, such as Adobe Stock, Canva and Pexels.
Information and exclusion
APIMAB LABORATOIRES implements all means it has available to ensure reliable information and reliable updating of its web pages. Nevertheless, errors or omissions may arise. Internet users must therefore ensure the accuracy of the information from APIMAB LABORATOIRES, and indicate all modifications to the site that they consider useful. APIMAB LABORATOIRES is in no case liable for the use of this information, and any direct or indirect damages which may arise from it.
The web pages of APIMAB LABORATOIRES may offer links to other websites or other resources available on the internet.
APIMAB LABORATOIRES does not have any way to control the sites connected with its web pages. APIMAB LABORATOIRES is not responsible for the availability of such sites or external resources, and does not guarantee them. It cannot be held liable for any damage of any nature resulting from content from these sites or external sources, notably for information, products or services that they offer, or any use that may be made of these elements. The risks linked with their use fall solely to the internet user, who must confirm their conditions of use.
Users, subscribers and visitors of the web pages of APIMAB LABORATOIRES cannot put in place a hyperlink to this site without the prior written authorisation of APIMAB LABORATOIRES.
In the case of a user or visitor wishing to put in place a hyperlink to one of the web pages of APIMAB LABORATOIRES, they must send a clear email to the website in order to request implementing a hyperlink. APIMAB LABORATOIRES reserves the right of accepting or refusing a hyperlink without having to justify its decision.
Furthermore, forwarding to a website to complete information sought does not signify in any way that APIMAB LABORATOIRES recognises or accepts any liability for the content or use of this site.
Precautions of use
Consequently, it is up to you to take the necessary precautions to ensure that your use does not lead to errors, with elements of a destructive nature such as viruses, trojan horses, etc.
No other guarantee is granted to the client, who is obligated to clearly formulate their needs and must be informed. If the information provided by APIMAB LABORATOIRES appears to be imprecise, the client must verify the consistency or credibility of the results obtained. APIMAB LABORATOIRES will in no way be liable toward third parties for the client’s use of the information or its absence in its products, including on its web pages.
APIMAB LABORATOIRES is at your service for all your comments or suggestions. You can write to use in French by emailing email@example.com.